Gender Differences in Long-Term Survival after Surgery for Non-Small Cell Lung Cancer

Yukihiro Yoshida, Tomonori Murayama, Yasunori Sato, Yoshio Suzuki, Haruhisa Saito, Yukihiro Nomura

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background This retrospective study examined gender differences in non-small cell lung cancer (NSCLC) by analyzing surgical cases at a single institution. Patients and Methods In this study, 735 NSCLC patients who underwent surgery from 1995 to 2010 were included. Clinical and pathological characteristics were retrieved by reviewing charts retrospectively, and variables between genders were compared. Results There were 489 males and 246 females in the study. The percentage of screening-detected lung cancers (83.7%), never smokers (82.9%), adenocarcinoma histology (90.7%), and pathological stage IA (42.7%) was higher in females than that in males (71.2, 8.2, 51.3, and 23.1%, respectively). Female patients had fewer cases of coronary artery disease (2.8%) and fewer pneumonectomy cases (2.0%) than the male patients (7.4 and 5.3%, respectively). The median follow-up period after surgery was 5.9 years. The overall survival rates at 5 years were 57.3% for males and 76.2% for females (p < 0.001, log-rank test). Based on univariate analysis, we report that histology, smoking history, and pathological stage were significant prognostic factors in addition to gender. Based on multivariate analysis, pathological stage III/IV (hazard ratio, 3.60; 95% confidence interval [CI], 2.84-4.54) and female gender (hazard ratio, 0.55; 95% CI, 0.37-0.82) were significant prognostic factors. Subgroup analysis demonstrated that female gender and adenocarcinoma histology were significant positive prognostic factors only in pathological stages I and II (n = 557). Conclusion Female gender as well as pathological stage was favorable prognostic factors. The survival advantage observed in female NSCLC patients was limited to those with cancer at stages I and II.

Original languageEnglish
Pages (from-to)507-514
Number of pages8
JournalThoracic and Cardiovascular Surgeon
Volume64
Issue number6
DOIs
Publication statusPublished - 2016 Sep 1
Externally publishedYes

Fingerprint

Non-Small Cell Lung Carcinoma
Survival
Histology
Adenocarcinoma
Confidence Intervals
Pneumonectomy
Coronary Artery Disease
Lung Neoplasms
Multivariate Analysis
Survival Rate
Retrospective Studies
Smoking
History
Neoplasms

Keywords

  • histology
  • imaging
  • lung cancer treatment
  • outcomes
  • pathology

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Gender Differences in Long-Term Survival after Surgery for Non-Small Cell Lung Cancer. / Yoshida, Yukihiro; Murayama, Tomonori; Sato, Yasunori; Suzuki, Yoshio; Saito, Haruhisa; Nomura, Yukihiro.

In: Thoracic and Cardiovascular Surgeon, Vol. 64, No. 6, 01.09.2016, p. 507-514.

Research output: Contribution to journalArticle

Yoshida, Y, Murayama, T, Sato, Y, Suzuki, Y, Saito, H & Nomura, Y 2016, 'Gender Differences in Long-Term Survival after Surgery for Non-Small Cell Lung Cancer', Thoracic and Cardiovascular Surgeon, vol. 64, no. 6, pp. 507-514. https://doi.org/10.1055/s-0035-1558995
Yoshida, Yukihiro ; Murayama, Tomonori ; Sato, Yasunori ; Suzuki, Yoshio ; Saito, Haruhisa ; Nomura, Yukihiro. / Gender Differences in Long-Term Survival after Surgery for Non-Small Cell Lung Cancer. In: Thoracic and Cardiovascular Surgeon. 2016 ; Vol. 64, No. 6. pp. 507-514.
@article{47d3403d74124d6d83fda21ea08775c5,
title = "Gender Differences in Long-Term Survival after Surgery for Non-Small Cell Lung Cancer",
abstract = "Background This retrospective study examined gender differences in non-small cell lung cancer (NSCLC) by analyzing surgical cases at a single institution. Patients and Methods In this study, 735 NSCLC patients who underwent surgery from 1995 to 2010 were included. Clinical and pathological characteristics were retrieved by reviewing charts retrospectively, and variables between genders were compared. Results There were 489 males and 246 females in the study. The percentage of screening-detected lung cancers (83.7{\%}), never smokers (82.9{\%}), adenocarcinoma histology (90.7{\%}), and pathological stage IA (42.7{\%}) was higher in females than that in males (71.2, 8.2, 51.3, and 23.1{\%}, respectively). Female patients had fewer cases of coronary artery disease (2.8{\%}) and fewer pneumonectomy cases (2.0{\%}) than the male patients (7.4 and 5.3{\%}, respectively). The median follow-up period after surgery was 5.9 years. The overall survival rates at 5 years were 57.3{\%} for males and 76.2{\%} for females (p < 0.001, log-rank test). Based on univariate analysis, we report that histology, smoking history, and pathological stage were significant prognostic factors in addition to gender. Based on multivariate analysis, pathological stage III/IV (hazard ratio, 3.60; 95{\%} confidence interval [CI], 2.84-4.54) and female gender (hazard ratio, 0.55; 95{\%} CI, 0.37-0.82) were significant prognostic factors. Subgroup analysis demonstrated that female gender and adenocarcinoma histology were significant positive prognostic factors only in pathological stages I and II (n = 557). Conclusion Female gender as well as pathological stage was favorable prognostic factors. The survival advantage observed in female NSCLC patients was limited to those with cancer at stages I and II.",
keywords = "histology, imaging, lung cancer treatment, outcomes, pathology",
author = "Yukihiro Yoshida and Tomonori Murayama and Yasunori Sato and Yoshio Suzuki and Haruhisa Saito and Yukihiro Nomura",
year = "2016",
month = "9",
day = "1",
doi = "10.1055/s-0035-1558995",
language = "English",
volume = "64",
pages = "507--514",
journal = "Thoracic and Cardiovascular Surgeon",
issn = "0171-6425",
publisher = "Georg Thieme Verlag",
number = "6",

}

TY - JOUR

T1 - Gender Differences in Long-Term Survival after Surgery for Non-Small Cell Lung Cancer

AU - Yoshida, Yukihiro

AU - Murayama, Tomonori

AU - Sato, Yasunori

AU - Suzuki, Yoshio

AU - Saito, Haruhisa

AU - Nomura, Yukihiro

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Background This retrospective study examined gender differences in non-small cell lung cancer (NSCLC) by analyzing surgical cases at a single institution. Patients and Methods In this study, 735 NSCLC patients who underwent surgery from 1995 to 2010 were included. Clinical and pathological characteristics were retrieved by reviewing charts retrospectively, and variables between genders were compared. Results There were 489 males and 246 females in the study. The percentage of screening-detected lung cancers (83.7%), never smokers (82.9%), adenocarcinoma histology (90.7%), and pathological stage IA (42.7%) was higher in females than that in males (71.2, 8.2, 51.3, and 23.1%, respectively). Female patients had fewer cases of coronary artery disease (2.8%) and fewer pneumonectomy cases (2.0%) than the male patients (7.4 and 5.3%, respectively). The median follow-up period after surgery was 5.9 years. The overall survival rates at 5 years were 57.3% for males and 76.2% for females (p < 0.001, log-rank test). Based on univariate analysis, we report that histology, smoking history, and pathological stage were significant prognostic factors in addition to gender. Based on multivariate analysis, pathological stage III/IV (hazard ratio, 3.60; 95% confidence interval [CI], 2.84-4.54) and female gender (hazard ratio, 0.55; 95% CI, 0.37-0.82) were significant prognostic factors. Subgroup analysis demonstrated that female gender and adenocarcinoma histology were significant positive prognostic factors only in pathological stages I and II (n = 557). Conclusion Female gender as well as pathological stage was favorable prognostic factors. The survival advantage observed in female NSCLC patients was limited to those with cancer at stages I and II.

AB - Background This retrospective study examined gender differences in non-small cell lung cancer (NSCLC) by analyzing surgical cases at a single institution. Patients and Methods In this study, 735 NSCLC patients who underwent surgery from 1995 to 2010 were included. Clinical and pathological characteristics were retrieved by reviewing charts retrospectively, and variables between genders were compared. Results There were 489 males and 246 females in the study. The percentage of screening-detected lung cancers (83.7%), never smokers (82.9%), adenocarcinoma histology (90.7%), and pathological stage IA (42.7%) was higher in females than that in males (71.2, 8.2, 51.3, and 23.1%, respectively). Female patients had fewer cases of coronary artery disease (2.8%) and fewer pneumonectomy cases (2.0%) than the male patients (7.4 and 5.3%, respectively). The median follow-up period after surgery was 5.9 years. The overall survival rates at 5 years were 57.3% for males and 76.2% for females (p < 0.001, log-rank test). Based on univariate analysis, we report that histology, smoking history, and pathological stage were significant prognostic factors in addition to gender. Based on multivariate analysis, pathological stage III/IV (hazard ratio, 3.60; 95% confidence interval [CI], 2.84-4.54) and female gender (hazard ratio, 0.55; 95% CI, 0.37-0.82) were significant prognostic factors. Subgroup analysis demonstrated that female gender and adenocarcinoma histology were significant positive prognostic factors only in pathological stages I and II (n = 557). Conclusion Female gender as well as pathological stage was favorable prognostic factors. The survival advantage observed in female NSCLC patients was limited to those with cancer at stages I and II.

KW - histology

KW - imaging

KW - lung cancer treatment

KW - outcomes

KW - pathology

UR - http://www.scopus.com/inward/record.url?scp=84941702720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941702720&partnerID=8YFLogxK

U2 - 10.1055/s-0035-1558995

DO - 10.1055/s-0035-1558995

M3 - Article

C2 - 26366891

AN - SCOPUS:84941702720

VL - 64

SP - 507

EP - 514

JO - Thoracic and Cardiovascular Surgeon

JF - Thoracic and Cardiovascular Surgeon

SN - 0171-6425

IS - 6

ER -